| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 110, 1828-1830, Copyright © 1982 by Endocrine Society
ARTICLES |
B Sharp, R Ross, E Levin and J Sowers
Intravenous administration of the dopamine antagonists domperidone and metoclopramide elevates canine plasma beta-endorphin immunoreactivity. Pretreatment with dopamine, but not dexamethasone, inhibits this effect. Sephadex G-50 chromatography shows that this response is due to beta-endorphin-like peptides, not beta-lipotropin. These findings indicate that pituitary beta-endorphin secretion is tonically inhibited by dopamine and suggest that the intermediate lobe is the source of this secretion.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |